Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.172ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.172ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.172ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.172NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.110ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.110ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.110ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.320ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.320ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.320ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.320NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.91ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.91ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.91ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.91NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GS.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.55.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.55.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.55.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.55.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LQ.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LQ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LQ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.62ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.62NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used